Human medicines European public assessment report EPAR Remicade infliximab Spondylitis AnkylosingArthritis RheumatoidPsoriasisCrohn DiseaseArthritis PsoriaticColitis Ulcerative Date of authorisation 13081999 Revision 55 Status Author

Human medicines European public assessment report EPAR Remicade infliximab Spondylitis AnkylosingArthritis RheumatoidPsoriasisCrohn DiseaseArthritis PsoriaticColitis Ulcerative Date of authorisation 13081999 Revision 55 Status Authorised